Spots Global Cancer Trial Database for botensilimab
Every month we try and update this database with for botensilimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas | NCT06346197 | Gastric Cancer MSI-H Metastatic Canc... Advanced Cancer | Balstilimab Botensilimab Folfox Protocol XELOX Nivolumab | 18 Years - | Centre Leon Berard | |
| KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer | NCT06411691 | Colorectal Canc... Pancreatic Canc... | KRAS Vaccine wi... Balstilimab Botensilimab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma | NCT05864534 | Newly Diagnosed... Glioblastoma, I... Gliosarcoma Glioblastoma Mu... | Balstilimab Botensilimab Liposomal Doxor... Sonocloud-9 (SC... | 18 Years - | Northwestern University | |
| A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer | NCT05630183 | Metastatic Panc... | Botensilimab Gemcitabine Nab-paclitaxel | 18 Years - | Agenus Inc. | |
| Botensilimab and Balstilimab Optimization in Colorectal Cancer | NCT06268015 | Colorectal Canc... | Botensilimab Balstilimab Oxaliplatin Leucovorin Fluorouracil Bevacizumab Panitumumab | 18 Years - | Duke University | |
| A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer | NCT06251973 | Metastatic Esop... Advanced Unrese... Metastatic Gast... Metastatic Gast... Metastatic Esop... Metastatic Esop... Metastatic Gast... Metastatic Gast... Unresectable Es... Unresectable Es... Unresectable Ga... Unresectable Ga... Unresectable Ga... | AgenT-797 Botensilimab Balstilimab Ramucirumab Paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations | NCT06279130 | Resectable MMR-... Resectable MMR-... | botensilimab balstilimab | 18 Years - | The Netherlands Cancer Institute | |
| A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer | NCT05630183 | Metastatic Panc... | Botensilimab Gemcitabine Nab-paclitaxel | 18 Years - | Agenus Inc. | |
| Study of AGEN1571 in Participants With Advanced Solid Tumors | NCT05377528 | Advanced Solid ... | AGEN1571 Balstilimab Botensilimab | 18 Years - | Agenus Inc. | |
| Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial | NCT05928806 | Advanced Renal ... | Botensilimab Balstilimab Ipilimumab Nivolumab | 18 Years - | Hoosier Cancer Research Network | |
| A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer | NCT05608044 | Metastatic Colo... | Botensilimab Balstilimab Standard of Car... | 18 Years - | Agenus Inc. | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute | |
| Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer | NCT06336902 | Metastatic Colo... Stage IV Colore... | Balstilimab Biospecimen Col... Botensilimab Computed Tomogr... Dietary Interve... Magnetic Resona... Vitamin C | 18 Years - | University of Southern California | |
| A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer | NCT05608044 | Metastatic Colo... | Botensilimab Balstilimab Standard of Car... | 18 Years - | Agenus Inc. | |
| Combination Immunotherapy in Colorectal Cancer | NCT05571293 | Colorectal Neop... | Botensilimab Balstilimab | 18 Years - | Weill Medical College of Cornell University | |
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer | NCT03860272 | Advanced Cancer Angiosarcoma Colorectal Canc... Endometrial Can... Fibrolamellar C... Non-small-cell ... Ovarian Cancer Prostate Cancer | Botensilimab Balstilimab | 18 Years - | Agenus Inc. | |
| Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer | NCT04121676 | Advanced Cancer | AGEN2373 Botensilimab | 18 Years - | Agenus Inc. | |
| Botensilimab and Balstilimab Optimization in Colorectal Cancer | NCT06268015 | Colorectal Canc... | Botensilimab Balstilimab Oxaliplatin Leucovorin Fluorouracil Bevacizumab Panitumumab | 18 Years - | Duke University | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
